Pricing of Innovative Drugs: Correlation Between Incremental Cost and Survival Gain in Four Countries

Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758834016644465
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

SAGE Publications

Related search

Coincident Demand Based Smart Long Run Incremental Cost Pricing Model

2014English

Php140 - Current Challenges and Potential Solution for Pricing Regulatory and Reimbursement Framework of Innovative Drugs in Egypt

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pricing Drugs

Health Affairs
MedicineHealth Policy
2003English

Pricing in Networking Innovative Processes

2017English

Comparison of Incremental Cost-Utility Ratios and Sales of Direct Oral Anticoagulants Across Eu-5 Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pcn286 - Incremental Cost-Effectiveness Ratio for the Antineoplastic Drugs Approved and Rejected for the Vital and Essential Drugs List in 2017 in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Correlation Between Maternal Weight Gain During Pregnancy and the Occurrence of Stunting in Infants

2017English

Drugs in Developing Countries

BMJ
1986English

Lack of Correlation Between the Costs of Anticancer Drugs and Clinical Benefits in Japan

Cancer Science
Cancer ResearchMedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy